TGIF2 and cervical carcinoma: The clinical relevance of SOX2 in PC was consistent with that of TGIF2, which also prevailed of TGIF2 in lung cancer and cervical cancer 47, 48 and SOX2 in cervical cancer 49, colorectal cancer 50, and urethral carcinoma 51.